BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $9.7 million in its first quarter.

The Burlingame, California-based company said it had a loss of 24 cents per share.

The biopharmaceutical company posted revenue of $2.4 million in the period.

In the final minutes of trading on Tuesday, the company's shares hit $4.43. A year ago, they were trading at $4.90.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News